Remove tag silico-modelling
article thumbnail

AI is critical to solving new complexities in drug discovery

Drug Discovery World

It also carries a much higher price tag for failure. Utilising AI, it is possible to build in silico models of any disease using dozens of heterogenous, human-derived data sources, then integrating potential treatments against that data in one process, breaking that data silo we face in traditional drug discovery avenues.

Drugs 52
article thumbnail

What to expect from PEGS Europe 2023: Day 3

Drug Discovery World

PLM and generative modelling for de novo degisn This session will begin with chairperson’s remarks from Victor Greiff, PhD, Associate Professor, Immunology, University of Oslo. Ali Madani, PhD, Founder and CEO, Profluent Bio, on: ‘Protein engineering with large language models’.

Protein 59